Carregant...
Prognostic impact of elevated fatty acid‐binding protein 1 in patients with heart failure
AIMS: Few biomarkers to evaluate pathophysiological changes in extra‐cardiac tissues have been identified in patients with heart failure (HF). Fatty acid‐binding protein 1 (FABP), also known as liver FABP, is predominantly expressed in the liver. Circulating FABP1 has been proposed to be a sensitive...
Guardat en:
| Publicat a: | ESC Heart Fail |
|---|---|
| Autors principals: | , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8006713/ https://ncbi.nlm.nih.gov/pubmed/33539661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13239 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|